Healthcare

By

Bruce Kamich

 | Jan 29, 2016 | 9:37 AM EST

Prices could find some support or buying interest at $80.

By

Robert Lang

 | Jan 28, 2016 | 12:00 PM EST

Is the biotech company's stock on its way higher?

By

Robert Lang

 | Jan 28, 2016 | 9:00 AM EST

The stock may be on its way higher.

By

Mike Norman

 | Jan 27, 2016 | 3:00 PM EST

Here's a single-payer system that works pretty well.

By

Chris Laudani

 | Jan 26, 2016 | 11:00 AM EST

BIIB needs to announce some top-line suprises when it reports on Wednesday to spark investor enthusiasm.

By

Bret Jensen

 | Jan 26, 2016 | 10:00 AM EST

Celgene, AbbVie and Gilead are set to report earnings. Here's what to look for.

By

Thomas Ward

 | Jan 23, 2016 | 12:00 PM EST

Two significant, but subtle forces may threaten the group in the next 12 months.

By

Bret Jensen

 | Jan 22, 2016 | 9:00 AM EST

This small-cap biotech has several 'shots on goal' as well as funding in place.

By

Skip Raschke

 | Jan 21, 2016 | 8:50 AM EST

This biotech is not as high-risk a play as you might think.

 

By

Bret Jensen

 | Jan 17, 2016 | 2:00 PM EST

Each of these small-caps delivered good news recently, only to have their stocks decline.

I have been adding on a scale.
My cost basis is about $95.80

Post coming in my Diary.

Stocks rebound from early losses after Japan turns in 5% loss overnight and Asia weak. Nic...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.